What is the normal range of human epitesticular protein 4?

Ovaries are very important to women. If the ovarian function is abnormal, it will cause great harm to women's health. Ovarian cancer is a common female disease with a high incidence rate. Human epitesticular protein 4 is usually used to detect whether there is ovarian cancer. If human epitesticular protein 4 exceeds the normal range, the possibility of suffering from ovarian cancer is very high. What is the normal range of human epitesticular protein 4?

Normal range of human epitesticular protein 4

The normal reference range of human epitesticular protein 4 is 0 to 90 pmol/L. Human epitesticular protein 4 is a sensitive indicator for detecting ovarian cancer and is one of the tumor markers. Compared with the carbohydrate antigen CA125, it is less affected by external factors. CA125 is generally affected by many factors such as inflammation, endometriosis, pregnancy, etc., which can cause an increase, while human epitesticular protein 4 is generally not affected by these factors. The combined detection of human epitesticular protein 4 and CA125 is more meaningful for the examination of ovarian cancer.

The dangers of ovarian cancer

Ovarian cancer can cause pain in the patient's waist and abdomen, which is the result of infiltration of the tissues adjacent to the ovaries. Ovarian cancer can easily cause sex hormone disorders in patients. If the patient suffers from testicular blastoma, it will often secrete excessive amounts of male hormones, making women more and more masculine. Ovarian cancer can easily cause gastrointestinal discomfort in the early stages of the disease. If women often have symptoms of gastrointestinal discomfort in their lives, after excluding gastrointestinal diseases, they should consider visiting a gynecologist.

As the ovarian cancer tumor grows, the patient's pelvic veins will be compressed by the tumor, and blood circulation will not be normal. First, the patient will experience edema of the vulva and lower limbs. Most ovarian cancer patients do not have obvious changes in menstruation in the early stages, but as the disease worsens, the normal functional tissue of the ovary will be destroyed by cancer cells, causing menstrual disorders, and some patients may even experience amenorrhea.

In addition to the above-mentioned harms to patients, ovarian cancer will also have a huge impact on patients' normal life and work, such as low back and abdominal pain, difficulty urinating and defecating, and even affecting the respiratory system, and threatening the patient's life.